Thyroid disease

Changing Iodine Status and the Incidence of Thyroid Disease in Mainland China: A Prospective 20-Year Follow-Up Study

ThyroidPublished Prospective cohort study

Authors' conclusion

The incidence of thyroid disorders (except for thyroid nodules) stabilized or decreased among adults in the three communities from year 5 to year 15 of follow-up.

Study context

Population
Adults in three regions of north China, followed in a cohort started in 1999; questionnaires, thyroid US, UIC, serum thyroid hormones and thyroid antibodiescohort started 1999
Participants
3,761 adults
Exposure
Regions with shifts in iodine status: Panshan and Huanghua vs Zhangwu
Outcome
Incidence of thyroid disorders after shifts in iodine status
Follow-up
Up to another 15 years after initial 5 years
Methodological details20-year follow-up, cluster sampling, three regions in north China
  • 20-year follow-up
  • Cluster sampling
  • Three regions in north China

Main finding

As reported in the abstract

Incidence density of thyroid disorders
Panshan (insufficient to adequate): incidence density of subclinical hyperthyroidism, positive TPOAb, positive thyroglobulin antibody (TgAb) and goiter decreased significantly
p < 0.05 for all
Huanghua (excessive to more than adequate): significant decrease in incidence density of subclinical hyperthyroidism, positive thyroid antibodies, positive TgAb and goiter
p < 0.05 for all
Huanghua: increase in thyroid nodule incidence density
17.26 vs. 28.25 per 1000 person-years, p < 0.001

Observational data: associations, not effects.

Further findings

OutcomePanshanZhangwuP value
Cumulative incidence of SCHPanshan vs Zhangwu · significantly lower with Panshan1.9%6.0%P < 0.001

Original publication

Changing Iodine Status and the Incidence of Thyroid Disease in Mainland China: A Prospective 20-Year Follow-Up Study. Thyroid. Published 26 May 2023. doi:10.1089/thy.2022.0505

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.